Treatment of heart failure with celiprolol, a cardioselective beta blocker with beta-2 agonist vasodilatory properties

American Journal of Cardiology

Volumn 85, Issue 12, 2000, Pages 1467-1471

  Witchitz, Serge ^a   Cohen Solal, Alain ^b   Dartois, Nathalie ^c   Weisslinger, Nadine ^c   Juste, Karine ^c   Darmon, Jean Yves ^c  

^a BICÊTRE HOSPITAL   (France)

^b BEAUJON HOSPITAL   (France)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; CELIPROLOL; METOPROLOL;

ADULT; AGED; ARTICLE; BETA ADRENERGIC STIMULATION; BRONCHUS DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXERCISE; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN DISEASE; VASODILATATION;

EID: 0034660225     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(00)00796-7     Document Type: Article

References (28)

1. Waagstein F., Bristow M.R., Swedberg K., Camerini F., Fowler M.B., Silver M.A., Gilbert E.M., Johnson M.R., Goss F.G., Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 342:1993;1441-1446.
2. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1994;1765-1773.
3. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
4. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation. 92:1995;212-219.
5. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
6. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial . Lancet. 353:1999;9-13.
7. Bristow M.R., Ginsburg R., Umans V., Fowler M., Minobe W., Rasmussen R., Zera P., Menlove R., Shah P., Jamieson S. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure . Circ Res. 59:1986;297-309.
8. Taylor S. Celiprolol and the heart. Am J Cardiol. 61:(suppl C):1988;34C-40C.
9. Milne R.J., Buckley M.M.T. Celiprolol an updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease . Drugs. 1991:1991;941-969.
10. Silke B., Thompson A., Riddell J.G. Contrasting actions of celiprolol and metoprolol on cardiac performance in normal volunteers. Cardiovasc Drugs Ther. 11:1997;57-61.
11. Goldman L., Hashimoto B., Cook E., Localzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class:advantages of a new specific activity scale. Circulation. 64:1981;1227-1234.
12. DiBianco R., Shabetai R., Kostuk W., Moran J., Schlant R., Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med. 320:1989;677-683.
13. Packer M. Effects of beta-adrenergic blockade on survival of patients with chronic heart failure. Am J Cardiol. 80:(suppl L):1997;46L-54L.
14. Heidenreich P.A., Lee T.T., Massie B.M. Effect of beta-blockade on mortality in patients with heart failure a meta-analysis of randomized clinical trials . J Am Coll Cardiol. 30:1997;27-34.
15. Lechat P., Packer M., Chalon S., Cucherat M., Arab T., Boissel J.P. Clinical effects of beta-adrenergic blockade in chronic heart failure a meta-analysis of double-blind, placebo-controlled, randomized trials . Circulation. 98:1998;1184-1191.
16. Doughty R.N., Rodgers A., Sharpe N., MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials. Eur Heart J. 18:1997;560-565.
17. Newton G.E., Parker J.D. Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation. 94:1996;353-358.
18. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. Lancet. 1:1988;489-493.
19. Nakamura Y., Tsutomu T., Tanaka N., Ohkusa T., Matsuzaki M. Celiprolol, a β-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity and survival in cardiomyopathic hamsters with advanced heart failure. J Cardiovasc Pharmacol. 31:1998;171-178.
20. Franciosa J., Ziesche S., Wilen H. Functional capacity of patients with chronic left ventricular failure:relationship of bicycle exercise performance to clinical and hemodynamic characterisation. Am J Med. 67:1979;460-466.
21. Lee T.H., Shammash J.B., Ribeiro J.P., Hartley L.H., Sherwood J., Goldman L. Estimation of maximum oxygen uptake from clinical data. Performance of the specific activity scale. Am Heart J. 115:1988;203-204.
22. Metra M., Nardi M., Giubbini R., Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 24:1994;1678-1687.
23. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., Kukin M.L., Schwartz B., Penn J., Medina N., Yushak M., Horn E., Katz S.D. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 92:1995;1499-1506.
24. Olsen S.L., Gilbert E.M., Renlund D.G., Taylor D.O., Yanowitz F.D., Bristow M.R. Carvedilol improves left ventricular function and symptoms in chronic heart failure a double-blind randomized study . J Am Coll Cardiol. 25:1995;1225-1231.
25. Woodley S.L., Gilbert E.M., Anderson J.L., O'Connell J.B., Deitchman D., Yanowitz F.G., Mealey P.C., Volkman K., Renlund D.G., Menlove R. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 84:1991;2426-2441.
26. Bristow M.R., O'Connell J.B., Gilbert E.M., French W.J., Leatherman G., Kantrowitz N.E., Orie J., Smucker M.L., Marshall G., Kelly P. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators Circulation. 89:1994;1632-1642.
27. Anderson J., Lutz J., Gilbert E., Sorensen S., Yanowitz F., Menelove R., Bartholomew M. A randomized trial of low-dose beta-blockade therapy for idiopathic cardiomyopathy. Am J Cardiol. 55:1985;471-475.
28. Sanderson J.E., Chan S.K., Yu C.M., Yeung L.Y., Chan W.M., Raymond K., Chan K.W., Woo K.S. Beta blockers in heart failure a comparison of a vasodilating beta blocker with metoprolol . Heart. 79:1998;86-92.